Company: CMND
Filing Date: 2025-12-05
Form Type: F-1/A
Source: 0001213900-25-118772
Chunk: 212

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-05
Form: F-1/A
Chunk 212
---
INCIPAL AND SELLING SHAREHOLDERS Major Shareholders The following table sets forth information with respect to the beneficial ownership of our ordinary Common Shares as of December 3, 2025 by:

| ● | each person or entity known by us to own beneficially 5% or more of our outstanding Common Shares; |
| ● | each of our directors and executive officers individually; and                                     |
| ● | all of our directors and executive officers as a group.                                            |

The beneficial ownership of our Common Shares is determined in accordance with the rules of the SEC and generally includes any shares over which a person exercises sole or shared voting or investment power, or the right to receive the economic benefit of ownership. For purposes of the table below, we deem options and RSUs that are currently exercisable or exercisable within 60 days of December 3, 2025 to be outstanding and to be beneficially owned by the person holding the options for the purposes of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person. Percentage of shares beneficially owned is based on 4,254,186 Common Shares issued and outstanding as of December 3, 2025. As of December 3, 2025, there were 60 holders of record of our Common Shares, out of which 4 holders of record had a registered address in the United States. To our knowledge, other than as disclosed in the table below, our other filings with the SEC and this Annual Report, there has been no significant change in the percentage ownership held by any major shareholder during the past three years. Except where otherwise indicated, we believe, based on information furnished to us by such owners, that the beneficial owners of the Common Shares listed below have sole investment and voting power with respect to such Common Shares. All of our shareholders, including the shareholders listed below, will have the same voting rights attached to their Common Shares, and neither our principal shareholders nor our directors and executive officers will have different or special voting rights with respect to their Common Shares. A description of any material relationship that our principal shareholders have had with us or any of our predecessors or affiliates within the past three years is included under “Related Party Transactions.” Unless otherwise noted below, the address of each shareholder, director and executive officer is c/o Clearmind Medicine Inc., 101 - 1220 West 6 thAvenue, Vancouver, British Columbia, V6H1A5.